Strategies for targeting residual HIV infection

July 31, 2016 at 12:29 pm

Current Opinion In HIV and AIDS July 2016 V.11 N.4 P.359–361

Chomont, Nicolas; Perreau, Matthieu

aCentre de Recherche du CHUM

bDepartment of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Quebec, Canada

cDivision of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland

Seven years ago, Hutter et al.[1] reported the unique case of a 40-year-old HIV-infected man who was cured of HIV infection following an allogeneic bone marrow transplant. Timothy Ray Brown, also known as the ‘Berlin Patient’ is until today the only person from whom HIV has been eradicated. This extraordinary and largely unexpected success fostered HIV cure research by opening novel therapeutic possibilities that could potentially surpass combination antiretroviral therapy (ART). Indeed, although ART has dramatically reduced the death rate from AIDS and improved the quality of life of many HIV-infected individuals, the possible long-term toxicity associated with ART, stigma and cost all contribute to the necessity of finding a cure….

FULL TEXT

http://journals.lww.com/co-hivandaids/Fulltext/2016/07000/Strategies_for_targeting_residual_HIV_infection.2.aspx

PDF (CLIC in PDF)

Entry filed under: Antirretrovirales, Biología Molecular, HIV/SIDA, HIV/SIDA HAART, Infecciones virales, Metodos diagnosticos, Update. Tags: .

Current approaches to assess HIV-1 persistence Working towards an understanding of bone disease in HIV


Calendar

July 2016
M T W T F S S
« Jun   Aug »
 123
45678910
11121314151617
18192021222324
25262728293031

Most Recent Posts


%d bloggers like this: